Logo image of ABIO

ARCA BIOPHARMA INC (ABIO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ABIO - US00211Y5069 - Common Stock

2.4 USD
-0.1 (-4%)
Last: 8/30/2024, 8:00:00 PM
2.48 USD
+0.08 (+3.33%)
After Hours: 8/30/2024, 8:00:00 PM
Fundamental Rating

3

ABIO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for ABIO as it has an excellent financial health rating, but there are worries on the profitability. ABIO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ABIO had negative earnings in the past year.
  • ABIO had a negative operating cash flow in the past year.
  • ABIO had negative earnings in each of the past 5 years.
  • In the past 5 years ABIO always reported negative operating cash flow.
ABIO Yearly Net Income VS EBIT VS OCF VS FCFABIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

  • ABIO has a better Return On Assets (-21.27%) than 77.82% of its industry peers.
  • ABIO's Return On Equity of -22.10% is amongst the best of the industry. ABIO outperforms 85.21% of its industry peers.
Industry RankSector Rank
ROA -21.27%
ROE -22.1%
ROIC N/A
ROA(3y)-24.11%
ROA(5y)-31.22%
ROE(3y)-25.36%
ROE(5y)-33.83%
ROIC(3y)N/A
ROIC(5y)N/A
ABIO Yearly ROA, ROE, ROICABIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ABIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABIO Yearly Profit, Operating, Gross MarginsABIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

8

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ABIO has more shares outstanding
  • There is no outstanding debt for ABIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ABIO Yearly Shares OutstandingABIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ABIO Yearly Total Debt VS Total AssetsABIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

  • ABIO has an Altman-Z score of 8.70. This indicates that ABIO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ABIO (8.70) is better than 84.33% of its industry peers.
  • ABIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.7
ROIC/WACCN/A
WACCN/A
ABIO Yearly LT Debt VS Equity VS FCFABIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 26.61 indicates that ABIO has no problem at all paying its short term obligations.
  • The Current ratio of ABIO (26.61) is better than 95.95% of its industry peers.
  • ABIO has a Quick Ratio of 26.61. This indicates that ABIO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 26.61, ABIO belongs to the top of the industry, outperforming 95.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 26.61
Quick Ratio 26.61
ABIO Yearly Current Assets VS Current LiabilitesABIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

  • The earnings per share for ABIO have decreased strongly by -13.18% in the last year.
EPS 1Y (TTM)-13.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-79.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABIO Yearly EPS VS EstimatesABIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2024 2025 2026 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ABIO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABIO Price Earnings VS Forward Price EarningsABIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABIO Per share dataABIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

  • ABIO has a Yearly Dividend Yield of 67.21%, which is a nice return.
  • The stock price of ABIO dropped by -35.14% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • ABIO's Dividend Yield is rather good when compared to the industry average which is at 1.08. ABIO pays more dividend than 99.82% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABIO pays a better dividend.
Industry RankSector Rank
Dividend Yield 67.21%

5.2 History

  • ABIO is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABIO Yearly Dividends per shareABIO Yearly Dividends per shareYearly Dividends per share 2024 5 10 15

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
ABIO Yearly Income VS Free CF VS DividendABIO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

More info and screens

ARCA BIOPHARMA INC / ABIO FAQ

What is the fundamental rating for ABIO stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABIO.


What is the valuation status for ABIO stock?

ChartMill assigns a valuation rating of 0 / 10 to ARCA BIOPHARMA INC (ABIO). This can be considered as Overvalued.


Can you provide the profitability details for ARCA BIOPHARMA INC?

ARCA BIOPHARMA INC (ABIO) has a profitability rating of 1 / 10.


Can you provide the financial health for ABIO stock?

The financial health rating of ARCA BIOPHARMA INC (ABIO) is 8 / 10.